Closing Bell: Aptose Biosciences Inc up on Wednesday (APS)
In today's trading, shares of Aptose Biosciences Inc opened at $0.69 and closed at $0.68. It traded at a low of $0.67 to a high of $0.69.
The price boosted 4.62% from the previous day's close of $0.65.
Today across North America, the TSX Composite closed -0.45% at 21880.95, the S&P 500 closed -0.77% at 5199.50, the Dow Jones Industrial Average closed -0.60% at 38763.45 and the Nasdaq Composite closed 1.03% at 16366.85.
Aptose Biosciences Inc traded under APS on the Toronto Stock Exchange (TSX).
Trading volume was 7,033 on 13 total trades. On average, Aptose Biosciences Inc has traded 7,810 shares over the last 5-days and 8,482 year-to-date.
The TSX market on the whole today saw 1,858 price advancers against 3,319 declines and 108 unchanged.
During the prior 52 weeks, APS.TO has traded as high as $6.90 (August 16,2023) and low as $0.60 (August 06,2024). Moreover, in the last 52 weeks, Aptose Biosciences Inc's shares have shrunken -86.37%, while this year, they have shrunken -79.70%.
Following today's trading, Aptose Biosciences Inc has a market capitalization of $11.77 million on a float of 18,109 shares outstanding. Its annual EPS is $-6.09.
Aptose Biosciences Inc is a None company headquartered in Toronto, CAN.
Currently, Aptose Biosciences Inc's consensus rating is "Strong Buy" based on 3 analysts according to Zacks. Currently, there are 3 buy ratings for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
